PD

Padma Duvvuri

Active Director Director DIN 01687434
DIN 01687434 First appointment Mar 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Mar 2006
Shareholding value •••• Premium profile

About Padma Duvvuri

Data last updated:

Padma Duvvuri is a Director at Phanicare Pharmaceuticals Private Limited (since 2016), Whole-Time Director at Konar Organics Limited (since 2007) and Director at Hps Laboratories Private Limited (since 2006), and holds 1 more current directorship. The companies operate in Pharma and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹109 Cr; the largest is Phanicare Pharmaceuticals Private Limited at ₹41.70 Cr (FY 2024). Earlier, Padma Duvvuri was a Nominee Director at Popular Polypack Private Limited (from 2010).

DIN 01687434
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2006
Oldest Company Age 38 yrs
Largest company Phanicare Pharmaceuticals Private Limited · ₹41.70 Cr (FY 2024)
Combined revenue ₹109 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Apr 20162003₹41.70 Cr (FY 2024)Active
Konar Organics Limited U24230TG1988PLC008215
Whole-Time Director25 Jun 20071988₹23.36 Cr (FY 2025)Active
Hps Laboratories Private Limited U24239TG2006PTC049581
Director23 Mar 20062006₹23.36 Cr (FY 2025)Active
Norrish Laboratories Private Limited U24233TG2012PTC084835
Director22 Sep 20232012₹20.76 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Popular Polypack Private Limited U24100TG1992PTC013648
Nominee Director04 Aug 20101992₹11.6 Lakh (FY 2022)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Popular Polypack Private Limited
Konar Organics Limited
Phanicare Pharmaceuticals Private Limited
Hps Laboratories Private Limited
Premium access

Shareholding and investment profile for Padma Duvvuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padma Duvvuri

Padma Duvvuri currently holds 4 directorships: Phanicare Pharmaceuticals Private Limited (Director, since 21 Apr 2016, revenue ₹41.70 Cr (FY 2024)); Konar Organics Limited (Whole-Time Director, since 25 Jun 2007, revenue ₹23.36 Cr (FY 2025)); Hps Laboratories Private Limited (Director, since 23 Mar 2006, revenue ₹23.36 Cr (FY 2025)); Norrish Laboratories Private Limited (Director, since 22 Sep 2023, revenue ₹20.76 Cr (FY 2024)).

Padma Duvvuri was first appointed on 23 Mar 2006 as Director at Hps Laboratories Private Limited. The most recent appointment on record is 22 Sep 2023 at Norrish Laboratories Private Limited.

The 4 current companies of Padma Duvvuri that report revenue have a combined latest revenue of ₹109 Cr: Phanicare Pharmaceuticals Private Limited ₹41.70 Cr (FY 2024); Konar Organics Limited ₹23.36 Cr (FY 2025); Hps Laboratories Private Limited ₹23.36 Cr (FY 2025); Norrish Laboratories Private Limited ₹20.76 Cr (FY 2024).

Padma Duvvuri held 1 earlier board appointment: Popular Polypack Private Limited (Nominee Director, from 04 Aug 2010).

The current boards of Padma Duvvuri's companies include Mallikarjuna Reddy Venati (Phanicare Pharmaceuticals Private Limited), Sumanth Karlapudi (Phanicare Pharmaceuticals Private Limited), Vishnuvardhan Reddy Devireddy (Phanicare Pharmaceuticals Private Limited), Sudhakar Reddy Venkati (Konar Organics Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available